The above evidence confirmed our view that ACAT1 promoted the proliferation and metastasis of BLCA cells by modulating the cell cycle and EMT through the AKT/GSK3β/c-Myc signaling pathway. The gene discussed is AKT1; the disease is bladder transitional cell carcinoma.